Correction: Favipiravir and/or nitazoxanide: a randomized, double-blind, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated at IMSS (FANTAZE)

Affiliations

• ¹ CINVESTAV-IPN, Mexico, Mexico. tania.smith@cinvestav.mx.
• ² CINVESTAV-IPN, Mexico, Mexico.
• ³ ICH-UCL, London, UK.
• ⁴ Clinical Trials Unit, UCL, London, UK.
• ⁵ IMSS, Mexico, Mexico.
• ⁶ Hakken Enterprise, Cuernavaca, Mexico.
• ⁷ University of Liverpool, Liverpool, UK.
• ⁸ Division of Infection and Immunity, UCL, London, UK.